Sinopharm
1099.HK
#1870
Rank
ยฃ6.85 B
Marketcap
ยฃ2.20
Share price
-0.23%
Change (1 day)
15.19%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Revenue for Sinopharm (1099.HK)

Revenue in 2023 (TTM): ยฃ52.27 Billion

According to Sinopharm's latest financial reports the company's current revenue (TTM ) is ยฃ63.72 Billion. In 2022 the company made a revenue of ยฃ63.72 Billion a decrease over the revenue in the year 2021 that were of ยฃ65.09 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sinopharm from 2006 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) ยฃ52.27 B-17.97%
2022 ยฃ63.72 B-2.1%
2021ยฃ65.09 B16.85%
2020ยฃ55.70 B14.95%
2019ยฃ48.46 B21.52%
2018ยฃ39.87 B5.93%
2017ยฃ37.64 B27.22%
2016ยฃ29.59 B5.37%
2015ยฃ28.08 B9.14%
2014ยฃ25.72 B17.22%
2013ยฃ21.94 B25.94%
2012ยฃ17.42 B34.61%
2011ยฃ12.94 B55.34%
2010ยฃ8.33 B35.79%
2009ยฃ6.13 B37.56%
2008ยฃ4.46 B31.43%
2007ยฃ3.39 B40.26%
2006ยฃ2.42 B